Particle Measuring Systems to Relocate Corporate Headquarters
PMS moves its headquarters to Boulder Technology Center in Niwot, Col.
Particle Measuring Systems (PMS) announced that it would be relocating its corporate headquarters from Airport Blvd. in Boulder, Col., to the Boulder Technology Center in Niwot, Col., on June 1, 2022. The company’s new base of operations is 124,000 ft2, more than twice as large as its current HQ, allowing it to house the manufacturing and business operations previously located in Boulder.
“This is a unique opportunity for us to design a space that accommodates the needs of all our employees while creating a positive customer and employee experience. This is a long-term strategic project for PMS and demonstrates significant capital investment by our parent company, Spectris. We are targeting operational occupancy of the building in early 2024,” said John Mitchell, president, PMS, in a company press release. “The vision for our new PMS HQ is to create an engaging, inclusive, and welcoming workplace with employees and customers in mind.”
Source: Particle Measuring Systems
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
